High dose toremifene in advanced breast cancer resistant to or relapsed during tamoxifen treatment Seppo PyrhönenRitva ValavaaraAlajos Hajba Report Pages: 223 - 228
Prognostic relevance of transforming growth factor alpha (TGF-α) and tumor necrosis factor alpha (TNF-α) detected in breast cancer tissues by immunohistochemistry Zsuzsa BebőkBéla MárkusPéter Németh Report Pages: 229 - 235
Breast cancer: prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features Ulf LönnSigrid LönnBjörn Stenkvist Report Pages: 237 - 245
Glucocorticoids and androgens up-regulate the Zn-α2-glycoprotein messenger RNA in human breast cancer cells Yolanda S. López-BoadoIrene Díez-ItzaCarlos López-Otín Report Pages: 247 - 258
Biological factors of prognostic significance in locally advanced breast cancer JFR RobertsonIO EllisRW Blamey Report Pages: 259 - 264
Lack of prognostic value of epidermal growth factor receptor in a series of 229 T1/T2, N0/N1 breast cancers, with well defined prognostic parameters M. BollaM. ChedinE. M. Chambaz Report Pages: 265 - 270
Results of chemotherapy using ifosfamide with doxorubicin in advanced breast cancer Michael MillwardMichael LindBrian Cantwell Report Pages: 271 - 277
Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen Josip LukačZvonko KusićAnte Bolanča Report Pages: 279 - 285
C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high risk I. SchönbornW. ZschiescheR. Grosse Report Pages: 287 - 295
DNA ploidy and S-phase fraction in medullary carcinoma of the breast -a flow cytometric analysis using archival material Lise PedersenJørgen K. LarsenTorben Schiødt Report Pages: 297 - 306
Antioxidant benefits of tamoxifen therapy for breast cancer? Helen WisemanCatherine Rice-EvansBarry Halliwell Correspondence Pages: 307 - 307
